GPR30 ESTROGEN RECEPTOR IN BREAST AND OVARIAN CANCERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100190199A1
SERIAL NO

12568581

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of prognosis for ovarian or breast cancer patients is carried out by detecting GPR30 in a sample of tissue. An elevation in the level of GPR30 compared to a normal control level indicates presentation of late stage disease and indicates responsiveness of the tumor to hormonal therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RHODE ISLAND HOSPITAL593 EDDY STREET PROVIDENCE RI 02903

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Filardo, Edward J East Grenwich, US 3 2
Sabo, Edmond Providence, US 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation